1. Giménez-Barcons M., Colobran R., Gómez-Pau A., Mar’-:n-SJnchez A., Casteras A., Obiols G., Abella R., FernJndez-Doblas J., Tonacchera M., Lucas-Mart’-:n A. and Pujol-Borrell R., (2015). Graves’ disease TSHR- stimulating antibodies (TSAbs).
2. Hammerstad S.S. and Tomer Y., (2015). Graves’ disease. A Comprehensive Guide for Clinicians; Chapter 3: 21–37.
3. Xander G.V., Erik E., Jan G. P. T. and Wilmar M. W., (2012). Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves’ hyperthyroidism. Eur. J. Endocrinol., 167(6): 783–92.
4. Elmugadam A.A., Elobied E.A., Mustafa H.A., Elfadil G.A. and Makeen A.M., (2014). Anti-TPO and Anti-Tg Antibodies in Sudanese Patients with Thyroid Diseases and Association of HLA Class- II with Graves’ disease. J. of Am. Sci., 10(2):3942.
5. Evaluation of Tumor Necrosis Factor-Alpha in Hepatitis C Virus with Diabetes Mellitus and Non Diabetes Mellitus patients